Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
Laura B Goddard
Overview
Structured Data
Issues
Contributors
Activity
All edits
Edits on 14 Dec, 2021
"Remove inverse infobox"
Golden AI
edited on 14 Dec, 2021
Edits made to:
Infobox
(
-127
properties)
Infobox
Patent primary examiner of
US Patent 11173196 Vectors for expression of prostate-associated antigens
US Patent 11179452 Antigen specific multi epitope vaccines
US Patent 11179474 Nanoparticle-based liver-targeting therapy and imaging
US Patent 11180813 Immunocompetence assessment by adaptive immune receptor diversity and clonality characterization
US Patent 7494976 Caveolin peptides and their use as therapeutics
US Patent 7495073 Short isoform of Annexin A10 at chromosome 4q, termed Annexin 10s (ANXA10s) and methods of use
US Patent 7498142 Methods of identifying combinations of antibodies with an improved anti-tumor activity and compositions and methods using the antibodies
US Patent 7501255 Levels of Pin1 in normal and cancerous tissue
US Patent 7521044 Human histone deacetylase, HDAC9c
US Patent 7544768 Peptides for inducing apoptosis in tumor cells
US Patent 7557204 CUDR as biomarker for cancer progression and therapeutic response
US Patent 7560111 HER2 antibody composition
US Patent 7563448 Modified vaccinia ankara expressing P53 in cancer immunotherapy
US Patent 7572442 Selected antibody compositions for binding to aminophospholipids
US Patent 7572448 Combined cancer treatment methods using selected antibodies to aminophospholipids
US Patent 7572887 Gene expressed in prostate cancer, methods and use thereof
US Patent 7579158 Cellular retinoic acid binding protein II as a marker for breast cancer
US Patent 7579452 Cancer vaccine based on brother of regulator of imprinted sites molecule
US Patent 7597894 Compositions and methods employing alternative reading frame polypeptides for the treatment of cancer and infectious disease
US Patent 7601826 Genes and polypeptides relating to human pancreatic cancers
US Patent 7604799 EphA4 Antibodies
US Patent 7604931 Cripto mutant and uses thereof
US Patent 7611704 Compositions and methods for treating viral infections using antibodies and immunoconjugates to aminophospholipids
US Patent 7611845 Serum levels of HER2/neu as an indicator of clinical state and prognosis of prostate cancer
US Patent 7615223 Selected immunoconjugates for binding to aminophospholipids
US Patent 7618936 Methods for treating and diagnosing cancer with WNT inhibitory Factor-1 (WIF-1)
US Patent 7622115 Treatment with anti-VEGF antibodies
US Patent 7622118 Cancer treatment methods using selected antibodies to aminophospholipids
US Patent 7625563 Cancer treatment methods using selected immunoconjugates for binding to aminophospholipids
US Patent 7625715 HIN-1, a tumor suppressor gene
US Patent 7638277 Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof
US Patent 7645589 Use of microphthalmia for diagnosis, prognosis and/or treatment of melanoma
US Patent 7645590 Method for distinguishing follicular thyroid adenoma (FTA) from follicular thyroid carcinoma (FTC)
US Patent 7651688 Method of modulating the activity of functional immune molecules to CD52
US Patent 7655228 Method of modulating the activity of functional immune molecules to GM2
US Patent 7655426 Ephrin-B receptor protein involved in carcinoma
US Patent 7662380 ZAQ ligand-1 antibodies and uses thereof
US Patent 7662776 Treatment of tumors using short peptides from human chorionic gonadotropin (HCG)
US Patent 7666393 Methods for assessing antiangiogenic agents
US Patent 7666603 Breast cancer related protein, gene encoding the same, and method of diagnosing breast cancer using the protein and gene
US Patent 7667018 Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
US Patent 7674468 Treatment of cancer using HSV mutant
US Patent 7678386 Liposomes coated with selected antibodies that bind to aminophospholipids
US Patent 7682610 Method of modulating the activity of functional immune molecules
US Patent 7682611 Method of modulating the activity of functional immune molecules to CXCR4 protein
US Patent 7687061 Method of modulating the activity of functional immune molecules to Her-2
US Patent 7691396 Chimeric peptides comprising HER-2 B-cell epitopes and measles virus fusion protein T-cell epitopes
US Patent 7700307 Mitochondrial stress-70 protein markers for colorectal cancer
US Patent 7704700 Methods for determining the prognosis for patients with a prostate neoplastic condition using inhibitor of apoptosis polypeptides
US Patent 7705141 Genes and polypeptides relating to human colon cancers
US Patent 7708997 Method of modulating the activity of functional immune molecules
US Patent 7709609 Tumor suppressor gene, p47ING3
US Patent 7718166 Immunotherapy for prostate cancer using recombinant bacille Calmette-Guerin expressing prostate specific antigens
US Patent 7718170 Alkaline phosphatase compositions to reduce skin cancer
US Patent 7718175 Method of modulating the activity of functional immune molecules to interleukin-5 receptor protein
US Patent 7718626 ErbB3 binding protein compositions and methods of use
US Patent 7727530 Anti-cancer composition comprising proline or its derivatives and an anti-tumour antibody
US Patent 7741445 Breast cancer resistance protein (BCRP) antibodies
US Patent 7759076 Quantitative ZAP-70 assay
US Patent 7763246 Method of modulating the activity of functional immune molecules to platelet-derived growth factor receptor
US Patent 7772202 Methods for treating breast cancer using NRIF3 related molecules
US Patent 7776342 Preparations that potentiate immunogenicity in low immunogenic antigens
US Patent 7776539 SENP1 as a marker for cancer
US Patent 7776550 Diagnosis of liver pathology through assessment of protein glycosylation
US Patent 7790159 Methods, combinations and kits for treating viral infections using immunoconjugates and antibodies to aminophospholipids
US Patent 7803382 Method for inducing immune response to NY-CO-58
US Patent 7807172 Methods and compositions for detecting thyroglobulin in a biological sample
US Patent 7811565 Antibodies and related molecules that bind to 161P2F10B proteins
US Patent 7811566 Antibody-induced apoptosis
US Patent 7811575 Nucleic acids and corresponding proteins entitled 158P3D2 useful in treatment and detection of cancer
US Patent 7812145 Short isoform of annexin A10 at chromosome 4q, termed annexin 10s (ANXA 10s) and methods of use
US Patent 7815906 Compositions and methods for restoring sensitivity to treatment with HER2 antagonists
US Patent 7829066 Assay for anti-metastatic agents
US Patent 7833736 Protein markers of responsiveness to type III receptor tyrosine kinase inhibitors
US Patent 7834169 P300 histone acetylase inhibitor
US Patent 7846683 Method for identifying agents which modulate cell growth or survival
US Patent 7846723 Methods of identifying anti-cancer agents and uses thereof
US Patent 7847065 CXADRL1 polypeptides relating to human cancers
US Patent 7851436 Inhibition of migration and induction of cell death by the type II collagen amino propeptides
US Patent 7854933 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
US Patent 7858331 Compositions and methods for the treatment of cancer
US Patent 7871788 Method of judging grade of malignancy of carcinoma cell using ATBF-1
US Patent 7875424 Identification of tumour-associated cell surface antigens for diagnosis and therapy
US Patent 7879325 HER2 antibody composition
US Patent 7879989 16836, A human phospholipase C family member, nucleic acids and uses thereof
US Patent 7887794 Lactic acid bacteria and their use in the treatment of cancer
US Patent 7887797 Immunoglobulin fractions
US Patent 7887801 Optimized DNA and protein sequence of an antibody to improve quality and yield of bacterially expressed antibody fusion proteins
US Patent 7901888 Multigene diagnostic assay for malignant thyroid neoplasm
US Patent 7902165 Use of AIM3 acting as a tumor suppressor
US Patent 7906115 Combinations kits and methods for treating viral infections using antibodies and immunoconjugates to aminophospholipids
US Patent 7910315 Early detection of hemangiosarcoma and angiosarcoma
US Patent 7919098 ErbB-3 based methods and compositions for treating neoplasms
US Patent 7919590 Tumor suppressor gene P33ING2
US Patent 7927597 Methods to inhibit cell growth
US Patent 7927806 Distinguishing PCA3 messenger RNA species in benign and malignant prostate tissues
US Patent 7927826 Method for distinguishing follicular thyroid adenoma (FTA) from follicular thyroid carcinoma (FTC)
US Patent 7932023 csPCNA isoform modifications and uses thereof
US Patent 7932031 Methods for determining sensitivity to microtubule-stabilizing agents comprising ixabepilone by measuring the level of estrogen receptor 1
US Patent 7932212 Inhibition of placenta growth factor (PlGF) mediated metastasis and/or angiogenesis
US Patent 7935784 HER-2 binding antagonists
US Patent 7935790 Reagents for the detection of protein phosphorylation in T-cell receptor signaling pathways
US Patent 7939072 Anti-EGFR antibodies with an improved anti-tumor activity and compositions and articles of manufacture comprising same
US Patent 7939090 System and method for the treatment of cancer, including cancers of the central nervous system
US Patent 7939251 SENP1 as a marker for cancer
US Patent 7939636 Reagents for the detection of protein phosphorylation in c-Src signaling pathways
US Patent 7943730 Genes and polypeptides relating to human pancreatic cancers
US Patent 7960112 Gene methylation in cancer diagnosis
US Patent 7960114 Gene signature of early hypoxia to predict patient survival
US Patent 7964349 Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
US Patent 7968294 SLIT2 underexpression in metastatic prostate cancer
US Patent 7968685 Antibodies against Tenascin-C
US Patent 7968686 Glucagon receptor antagonists
US Patent 7972594 Ablative immunotherapy
US Patent 7972602 Promiscuous HER-2/Neu CD4 T cell epitopes
US Patent 7972770 Methods of detection of cancer using peptide profiles
US Patent 7973134 Reagents for the detection of protein phosphorylation in anaplastic large cell lymphoma signaling pathways
US Patent 7976868 Liposomes comprising duramycin and anti-viral agents
US Patent 7977062 Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
US Patent 7981418 Predicting response to a HER inhibitor
US Patent 7981624 Methods to detect tumors using 20P1F12/TMPRSS2 expression
US Patent 7993829 HPRP4s modifiers of the p53 pathway and methods of use
US Patent 7993834 Detection of ErbB2 gene amplification to increase the likelihood of the effectiveness of ErbB2 antibody breast cancer therapy
US Patent 7998695 Method of diagnosing bladder cancer
US Patent 7999080 Reagents for the detection of protein phosphorylation in signaling pathways
US Patent 8007785 Method for treating colon cancer with tumour-reactive T-lymphocytes
US Patent 8008004 Compositions and methods for the diagnosis and treatment of tumors of glial origin
Edits on 8 Dec, 2021
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 8008004 Compositions and methods for the diagnosis and treatment of tumors of glial origin
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 8007785 Method for treating colon cancer with tumour-reactive T-lymphocytes
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7999080 Reagents for the detection of protein phosphorylation in signaling pathways
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7998695 Method of diagnosing bladder cancer
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7993834 Detection of ErbB2 gene amplification to increase the likelihood of the effectiveness of ErbB2 antibody breast cancer therapy
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7993829 HPRP4s modifiers of the p53 pathway and methods of use
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7981624 Methods to detect tumors using 20P1F12/TMPRSS2 expression
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7981418 Predicting response to a HER inhibitor
Edits on 8 Dec, 2021
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7977062 Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7976868 Liposomes comprising duramycin and anti-viral agents
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7973134 Reagents for the detection of protein phosphorylation in anaplastic large cell lymphoma signaling pathways
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7972770 Methods of detection of cancer using peptide profiles
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7972602 Promiscuous HER-2/Neu CD4 T cell epitopes
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7972594 Ablative immunotherapy
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7968686 Glucagon receptor antagonists
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7968685 Antibodies against Tenascin-C
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7968294 SLIT2 underexpression in metastatic prostate cancer
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7964349 Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7960114 Gene signature of early hypoxia to predict patient survival
Load more
Find more people like Laura B Goddard
Use the Golden Query Tool to discover related individuals, professionals, or experts with similar interests, expertise, or connections in the Knowledge Graph.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE